NeuroSense Therapeutics Ltd. (NRSN) Total Assets by Year

NRSN

NeuroSense Therapeutics Ltd. closed fiscal year 2025 with $1.0M in total assets, $2.6M in total liabilities and -$1.6M in shareholder equity. This represents a decrease of 77.5% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters NeuroSense Therapeutics Ltd. has filed alongside them.

FY2025 annual

Total Assets $1.0M

Total Liabilities $2.6M

Total Equity -$1.6M

YoY -77.5%

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Mar 31, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NRSN Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K
Total Assets	$1.0M-77.5%	$4.6M+43.6%	$3.2M-58.7%	$7.7M	N/A
Total Liabilities	$2.6M+29.9%	$2.0M-59.7%	$4.9M+164.0%	$1.9M	N/A
Total Equity	-$1.6M-160.4%	$2.6M+246.8%	-$1.8M-130.1%	$5.8M-46.1%	$10.8M

NRSN Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q4'2510-K	Q2'256-K	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q4'2210-K
Total Assets	$1.0M-77.5%	$1.7M-8.5%	$4.6M+43.6%	$1.8M	$3.2M-58.7%	$7.7M
Total Liabilities	$2.6M+29.9%	$2.2M-37.8%	$2.0M-59.7%	$3.5M	$4.9M+164.0%	$1.9M
Total Equity	-$1.6M-160.4%	-$519K+69.5%	$2.6M+246.8%	-$1.7M	-$1.8M-130.1%	$5.8M

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More NeuroSense Therapeutics Ltd. financials

Frequently Asked Questions

What was NeuroSense Therapeutics Ltd.'s total assets in fiscal year 2025?

NeuroSense Therapeutics Ltd. closed fiscal year 2025 with $1.0M in total assets, $2.6M in total liabilities and -$1.6M in shareholder equity.

How fast is NeuroSense Therapeutics Ltd.'s total assets growing?

NeuroSense Therapeutics Ltd. (NRSN) total assets fell by 77.5% year over year, from $4.6M to $1.0M in fiscal year 2025.

What was NeuroSense Therapeutics Ltd.'s total assets in the most recent quarter?

NeuroSense Therapeutics Ltd. (NRSN) reported $1.0M in total assets in Q4 2025. This represents a decrease of 77.5% from the same quarter a year earlier.

What does total assets mean on a financial statement?

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NeuroSense Therapeutics Ltd. (NRSN) reported on that line in every period on record.